SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism
Florian Mayr,
Vanessa Kruse,
Dominik C. Fuhrmann,
Sebastian Wolf,
Jens Löber,
Saed Alsouri,
Nadia Paglilla,
Kwang Lee,
Björn Chapuy,
Bernhard Brüne,
Thorsten Zenz,
Björn Häupl,
Thomas Oellerich,
Michael Engelke
Affiliations
Florian Mayr
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen
Vanessa Kruse
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen
Dominik C. Fuhrmann
Institute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt
Sebastian Wolf
Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt
Jens Löber
Department of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin
Saed Alsouri
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen
Nadia Paglilla
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen
Kwang Lee
Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg
Björn Chapuy
Department of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin
Bernhard Brüne
Institute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt
Thorsten Zenz
Department of Medical Oncology and Hematology, University Hospital Zurich
Björn Häupl
Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt
Thomas Oellerich
Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt
Michael Engelke
Institute for Cellular and Molecular Immunology, University Medical Center Göttingen
Burkitt lymphoma cells (BL) exploit antigen-independent tonic signals transduced by the B-cell antigen receptor (BCR) for their survival, but the molecular details of the rewired BL-specific BCR signal network remain unclear. A loss of function screen revealed the SH2 domain-containing 5`-inositol phosphatase 2 (SHIP2) as a potential modulator of BL fitness. We characterized the role of SHIP2 in BL survival in several BL cell models and show that perturbing SHIP2 function renders cells more susceptible to apoptosis, while attenuating proliferation in a BCR-dependent manner. Unexpectedly, SHIP2 deficiency did neither affect PI3K survival signals nor MAPK activity, but attenuated ATP production. We found that an efficient energy metabolism in BL cells requires phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), which is the enzymatic product of SHIP proteins. Consistently, interference with the function of SHIP1 and SHIP2 augments BL cell susceptibility to PI3K inhibition. Notably, we provide here a molecular basis of how tonic BCR signals are connected to energy supply, which is particularly important for such an aggressively growing neoplasia. These findings may help to improve therapies for the treatment of BL by limiting energy metabolism through the inhibition of SHIP proteins, which renders BL cells more susceptible to the targeting of survival signals.